• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高糖基化人干扰素-β R27T 变体的稳定性和活性。

Stability and Activity of the Hyperglycosylated Human Interferon-β R27T Variant.

机构信息

R&DB Center, LOGONE Bio-convergence Research Foundation, Seoul, Republic of Korea.

IFEZ Bio Analysis Center, Binex Co., Ltd., Incheon, Republic of Korea.

出版信息

Sci Rep. 2020 May 21;10(1):8412. doi: 10.1038/s41598-020-65495-y.

DOI:10.1038/s41598-020-65495-y
PMID:32439982
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7242330/
Abstract

A hyperglycosylated recombinant human interferon-β (rhIFN-β) R27T mutant was established to improve relapsing-remitting multiple sclerosis (RRMS) in our previous study. We focused on the stability of the R27T mutant throughout its production lifetime, including culture, purification, and storage before formulation prior to clinical use. Herein, we address the stability of this protein during optimized culture and purification processes. Additionally, we employed artificial stress conditions during culture and purification to characterize R27T instability. Although, among total R27T, relative native R27T ratio displayed transiently low even under optimized production process, the ratio was recovered by the end of the overall production process, suggesting that culture and purification processes are optimized. Artificial stress during culture and purification processes resulted in degradation of R27T acidic and basic variants, and mismatched disulfide bonds in no-aggregated forms as well as in the aggregated form. The presence of disulfide bond exchange without aggregation in the unfolded/misfolded state could be a novel finding for rhIFN-β products. The results provide meaningful information for the comprehensive evaluation of the stability of the R27T variant.

摘要

在我们之前的研究中,构建了一种高糖基化的重组人干扰素-β(rhIFN-β)R27T 突变体,以改善复发性多发性硬化症(RRMS)。我们关注的是该 R27T 突变体在整个生产寿命期间的稳定性,包括临床使用前的培养、纯化和制剂前的储存。在此,我们解决了在优化的培养和纯化过程中该蛋白的稳定性问题。此外,我们在培养和纯化过程中采用人工应激条件来表征 R27T 的不稳定性。尽管在优化的生产工艺下,总 R27T 中相对天然 R27T 的比例会短暂降低,但在整个生产过程结束时,该比例会恢复,这表明培养和纯化工艺得到了优化。在培养和纯化过程中,人工应激导致 R27T 酸性和碱性变体以及非聚集形式和聚集形式中的错配二硫键降解。在未聚集的展开/错误折叠状态下发生二硫键交换而不聚集可能是 rhIFN-β 产品的一个新发现。这些结果为 R27T 变体的稳定性综合评估提供了有意义的信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c1/7242330/0d12a5264c3f/41598_2020_65495_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c1/7242330/a0e479059416/41598_2020_65495_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c1/7242330/50f5a2e99738/41598_2020_65495_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c1/7242330/edb3bd6b4fba/41598_2020_65495_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c1/7242330/856fe8f14c4e/41598_2020_65495_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c1/7242330/0d12a5264c3f/41598_2020_65495_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c1/7242330/a0e479059416/41598_2020_65495_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c1/7242330/50f5a2e99738/41598_2020_65495_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c1/7242330/edb3bd6b4fba/41598_2020_65495_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c1/7242330/856fe8f14c4e/41598_2020_65495_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c1/7242330/0d12a5264c3f/41598_2020_65495_Fig5_HTML.jpg

相似文献

1
Stability and Activity of the Hyperglycosylated Human Interferon-β R27T Variant.高糖基化人干扰素-β R27T 变体的稳定性和活性。
Sci Rep. 2020 May 21;10(1):8412. doi: 10.1038/s41598-020-65495-y.
2
Glycoengineering of interferon-β 1a improves its biophysical and pharmacokinetic properties.糖基工程化干扰素-β 1a 可改善其物理化学性质和药代动力学特性。
PLoS One. 2014 May 23;9(5):e96967. doi: 10.1371/journal.pone.0096967. eCollection 2014.
3
Glycosylation Heterogeneity of Hyperglycosylated Recombinant Human Interferon-β (rhIFN-β).高糖基化重组人干扰素-β(rhIFN-β)的糖基化异质性
ACS Omega. 2020 Mar 20;5(12):6619-6627. doi: 10.1021/acsomega.9b04385. eCollection 2020 Mar 31.
4
Basal buffer systems for a newly glycosylated recombinant human interferon-β with biophysical stability and DoE approaches.具有生物物理稳定性的新糖基化重组人干扰素-β的基础缓冲系统及实验设计方法
Eur J Pharm Sci. 2015 Oct 12;78:177-89. doi: 10.1016/j.ejps.2015.07.020. Epub 2015 Jul 26.
5
High yields of monomeric recombinant beta-interferon from macroporous microcarrier cultures under hypothermic conditions.低温条件下大孔微载体培养中单体重组β-干扰素的高产率。
Biotechnol Prog. 2008 Jul-Aug;24(4):832-8. doi: 10.1002/btpr.8.
6
Differential effects of bioreactor process variables and purification on the human recombinant lysosomal enzyme β-glucuronidase produced from Chinese hamster ovary cells.生物反应器工艺参数和纯化对来源于中国仓鼠卵巢细胞的人重组溶酶体酶β-葡糖苷酸酶的差异影响。
Appl Microbiol Biotechnol. 2019 Aug;103(15):6081-6095. doi: 10.1007/s00253-019-09889-7. Epub 2019 Jun 7.
7
Rational design of glycoengineered interferon-β analogs with improved aggregation state: experimental validation.具有改善聚集状态的糖基工程化干扰素-β类似物的合理设计:实验验证
Protein Eng Des Sel. 2017 Jan;30(1):23-30. doi: 10.1093/protein/gzw058. Epub 2016 Nov 23.
8
A Glycoengineered Interferon-β Mutein (R27T) Generates Prolonged Signaling by an Altered Receptor-Binding Kinetics.一种糖基工程化干扰素-β 突变体(R27T)通过改变的受体结合动力学产生延长的信号传导。
Front Pharmacol. 2019 Jan 24;9:1568. doi: 10.3389/fphar.2018.01568. eCollection 2018.
9
Enhanced interferon-beta production by CHO cells through elevated osmolality and reduced culture temperature.通过提高渗透压和降低培养温度提高 CHO 细胞的干扰素-β产量。
Biotechnol Prog. 2009 Sep-Oct;25(5):1440-7. doi: 10.1002/btpr.234.
10
Sensitization of glycoengineered interferon-β1a-resistant cancer cells by cFLIP inhibition for enhanced anti-cancer therapy.通过抑制cFLIP使糖基工程化的抗干扰素-β1a癌细胞致敏以增强抗癌治疗。
Oncotarget. 2017 Feb 21;8(8):13957-13970. doi: 10.18632/oncotarget.14573.

引用本文的文献

1
Role of interferons in the antiviral battle: from virus-host crosstalk to prophylactic and therapeutic potential in SARS-CoV-2 infection.干扰素在抗病毒斗争中的作用:从病毒-宿主相互作用到 SARS-CoV-2 感染的预防和治疗潜力。
Front Immunol. 2024 Jan 15;14:1273604. doi: 10.3389/fimmu.2023.1273604. eCollection 2023.
2
Antibody-Based Targeting of Interferon-Beta-1a Mutein in HER2-Positive Cancer Enhances Antitumor Effects Through Immune Responses and Direct Cell Killing.基于抗体的HER2阳性癌症中干扰素-β-1a突变体靶向治疗通过免疫反应和直接细胞杀伤增强抗肿瘤作用。
Front Pharmacol. 2021 Jan 8;11:608774. doi: 10.3389/fphar.2020.608774. eCollection 2020.

本文引用的文献

1
Protein aggregation - Mechanisms, detection, and control.蛋白质聚集:机制、检测与控制。
Int J Pharm. 2018 Oct 25;550(1-2):251-268. doi: 10.1016/j.ijpharm.2018.08.043. Epub 2018 Aug 23.
2
Factors affecting the physical stability (aggregation) of peptide therapeutics.影响肽类治疗药物物理稳定性(聚集)的因素。
Interface Focus. 2017 Dec 6;7(6):20170030. doi: 10.1098/rsfs.2017.0030. Epub 2017 Oct 20.
3
Immunogenicity and other problems associated with the use of biopharmaceuticals.生物制药的免疫原性和其他问题。
Ther Adv Drug Saf. 2011 Jun;2(3):113-28. doi: 10.1177/2042098611406318.
4
Glycoengineering of interferon-β 1a improves its biophysical and pharmacokinetic properties.糖基工程化干扰素-β 1a 可改善其物理化学性质和药代动力学特性。
PLoS One. 2014 May 23;9(5):e96967. doi: 10.1371/journal.pone.0096967. eCollection 2014.
5
Characterization and quantitation of aggregates and particles in interferon-β products: potential links between product quality attributes and immunogenicity.干扰素-β产品中聚集体和颗粒的特性描述和定量:产品质量属性与免疫原性之间的潜在联系。
J Pharm Sci. 2013 Mar;102(3):915-28. doi: 10.1002/jps.23415. Epub 2012 Dec 11.
6
Disulfide bond formation and its impact on the biological activity and stability of recombinant therapeutic proteins produced by Escherichia coli expression system.二硫键的形成及其对大肠杆菌表达系统生产的重组治疗蛋白的生物活性和稳定性的影响。
Biotechnol Adv. 2011 Nov-Dec;29(6):923-9. doi: 10.1016/j.biotechadv.2011.07.013. Epub 2011 Jul 29.
7
Oxidized and aggregated recombinant human interferon beta is immunogenic in human interferon beta transgenic mice.氧化和聚集的重组人干扰素-β在人干扰素-β转基因小鼠中具有免疫原性。
Pharm Res. 2011 Oct;28(10):2393-402. doi: 10.1007/s11095-011-0451-4. Epub 2011 May 5.
8
High productivity of human recombinant beta-interferon from a low-temperature perfusion culture.低温灌流培养高效表达人重组β干扰素。
J Biotechnol. 2010 Dec;150(4):509-18. doi: 10.1016/j.jbiotec.2010.09.959. Epub 2010 Oct 8.
9
On the role of aggregates in the immunogenicity of recombinant human interferon beta in patients with multiple sclerosis.在多发性硬化症患者中,重组人干扰素 β 的免疫原性中聚集物的作用。
J Interferon Cytokine Res. 2010 Oct;30(10):767-75. doi: 10.1089/jir.2010.0086.
10
n-Dodecyl-β-D-maltoside inhibits aggregation of human interferon-β-1b and reduces its immunogenicity.正十二烷基-β-D-麦芽糖苷抑制人干扰素-β-1b 的聚集并降低其免疫原性。
J Neuroimmune Pharmacol. 2011 Mar;6(1):158-62. doi: 10.1007/s11481-010-9226-7. Epub 2010 Jun 8.